Oakland, CA, United States of America

Altaf Kassam


Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Altaf Kassam: Innovator in Cancer Research

Introduction

Altaf Kassam is a notable inventor based in Oakland, CA, who has made significant contributions to the field of cancer research. With a total of 5 patents to his name, Kassam's work focuses on the development of diagnostic and therapeutic methods for cancer treatment.

Latest Patents

Kassam's latest patents include "Gene products differentially expressed in cancerous cells and their methods of use II." This invention provides polynucleotides and polypeptides that are differentially expressed in cancer cells, which are useful in various diagnostic and therapeutic methods. Additionally, it offers methods for reducing the growth of cancer cells, making it a valuable tool for cancer treatment. Another significant patent is "Human genes and gene expression products V," which relates to novel human polynucleotides and their encoded polypeptides. This invention also encompasses diagnostic and therapeutic agents that utilize these novel human polynucleotides and their corresponding genes or gene products.

Career Highlights

Throughout his career, Kassam has worked with prominent companies such as Nuvelo, Inc. and Chiron Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and cancer research.

Collaborations

Kassam has collaborated with notable colleagues, including Christoph Reinhard and David Pot. These partnerships have likely enhanced his research and innovation efforts in cancer treatment.

Conclusion

Altaf Kassam is a distinguished inventor whose work in cancer research has led to important advancements in diagnostic and therapeutic methods. His contributions continue to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…